CHICAGO —IBgard showed significant efficacy in a combined group of patients with irritable bowel syndrome with both diarrhea and constipation, and patients with diarrhea-predominant IBS, at 24 hours and at 4 weeks, according to data from two posters presented at Digestive Disease Week.